
About


Re-Launch of UK’s Innovative Licensing and Access Pathway (“ILAP”)

MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?

The Covington European Life Sciences Symposium 2025

European Commission Consults on Update to Pharmacovigilance Rules

Are you Windsor Framework ready? A focus on pharmaceutical supply chains and promotional material

EMA Clinical Data Publication Policy to Cover All New Marketing Authorization Applications, Line Extensions and Major Clinical Type II Variations Starting Q2 2025
EU Talking Life Sciences Audiocast: Developments in the African Medicines Agency and Regulatory Convergence

New ABPI Code and PMCPA Constitution and Procedure Published
